Blog

rabbit-pyrogenicity

Ensuring Safety: Understanding ISO 10993-5 In Vitro Cytotoxicity Testing
rabbit-pyrogenicity

Understanding the Material Mediated Rabbit Pyrogenicity Test
cytotoxicity

Ensuring Safety and Efficacy: Implantation Testing for Medical Devices
novel-therapies

Novel Therapies for Diabetic Wound Healing: Insights from Rat Model Studies
scarring-animal-model-in-mice

Bleomycin-Induced Hypertrophic Scarring animal model in Mice
cytotoxicity

Ensuring Safety and Compliance: Navigating the ISO 10993-10 Standard
cytotoxicity

MTT Assay: A Vital Tool for Testing Medical Device Safety
hemocompatibility

Hemocompatibility Testing for Medical Devices
rna-technologies

Advances in RNA technologies

Intracutaneous Reactivity Tests for Medical Devices

Explore more about microbiome in human health

Importance of the Guinea Pig Maximization Test

Navigating Genotoxicity Testing in Medical Devices

Targeting Ribonucleases with Small Molecules and Bifunctional Molecules

Discovery of Orally Available and Brain Penetrant AEP Inhibitors

Tuning Molecular Strategies for a Clinically Sound Listening

The First Covalent FGFR Kinase Inhibitor in Clinical Use

Optimizing mTOR Inhibitors with Property-Based Drug Design

Pyrrolo[2,3-c]pyridines: LSD1 Inhibitors

Identification of: GDC 1971 Inhibitors

Identification of Thieno[3,2-d]pyrimidine derivatives

Pharmacokinetic-Pharmacodynamic (PK/PD) of Anti-infective Agents

Evaluating (PK/PD) Properties of Anti-infective Agents in Preclinical Models of Infection

ORGANOID MODELS FOR CANCER DRUG DISCOVERY

Hollow Fiber models in Cancer Drug Discovery

Patient Derived Xenograft models in Cancer Drug Discovery.

The mouse is the workhorse for cancer studies.

Biomarker can be DNA in a gene, mRNA, an enzyme or a protein.

circRNA in cancer

Send message